HIV Clinical Trial
— Connect4CareOfficial title:
Seek Test Treat Retain Strategies Leveraging Mobile Health Technologies
Verified date | February 2017 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Retention in care and virologic suppression are the key final steps of the HIV treatment
cascade. Poor or intermittent retention has been associated with later initiation of
antiretroviral therapy, virologic failure, and death. Regular HIV care has also been
associated with a decrease in HIV transmission risk behavior. Despite the proven health and
prevention benefits of consistent HIV care, only 40-50% of those infected with HIV in the
United States are estimated to meet current retention in care standards and even fewer -
only about 25% - are estimated to be virologically suppressed.
The Behavioral Model for Vulnerable Populations provides a useful framework for
understanding broad areas that may impact adherence to care and treatment. Individual-level
domains include vulnerable (e.g., depression, stigma), enabling (e.g., social support,
positive affect), and need (e.g., co-morbidities) factors, and structural domains include,
for example, features or the clinic and the provider-patient relationship.
Short message service (SMS) technology represents a new and exciting tool to help retain
HIV-infected patients in care and treatment. SMS interventions have been deployed
successfully in support of antiretroviral adherence and virologic suppression in sub-Saharan
Africa, where two randomized trials have showed clear benefits. A pilot study conducted in
our clinic suggests that use of SMS messages to promote adherence to care and treatment in
the urban HIV-infected poor is both feasible and acceptable.
The investigators believe that combining SMS technology with content-specific messages
designed to impact factors highlighted in the Behavioral Model for Vulnerable Populations
can improve retention in care and virologic suppression for an urban public hospital
population living with HIV, thus the investigators propose the following specific aims.
Specific Aim 1: Determine whether a behavioral theory-based SMS intervention improves
virologic suppression [primary outcome] and retention in care [secondary outcome] for a
vulnerable urban HIV-infected population through a randomized trial of this technology
compared to SMS appointment reminders alone. Retention in care will also be analyzed as a
mediator of virologic suppression. Exploratory outcomes include time to virologic
suppression, sustained virologic suppression, emergency department utilization and
antiretroviral adherence, as well as levels of depression, positive affect, social support
and empowerment.
Specific Aim 2: Examine patient experiences with the SMS intervention, focusing specifically
on: 1) satisfaction with this technology; 2) identifying barriers to and facilitators of
patient use of this technology, and; 3) the preferred frequency and content of intervention
messages.
Specific Aim 3: Conduct cost and cost-effectiveness analyses of the SMS intervention.
Status | Completed |
Enrollment | 230 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - HIV-infected - Age 18 or over - English-speaking - Able to give informed consent - Have a cell phone and willing to send/receive up to 25 text messages/month - Detectable viral load plus either 1) new to clinic (no more than 2 primary care visits) or 2) history of poor retention (one missed visit or lack of six-month visit constancy in the past year) Exclusion Criteria: - HIV-uninfected - Under age 18 - Monolingual speaker of a language other than English - Unable to give informed consent - Undetectable viral load - Perfect appointment adherence |
Country | Name | City | State |
---|---|---|---|
United States | San Francisco General Hospital Positive Health Program | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco |
United States,
Christopoulos KA, Riley ED, Tulsky J, Carrico AW, Moskowitz JT, Wilson L, Coffin LS, Falahati V, Akerley J, Hilton JF. A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial. BMC Infect Dis. 2014 Dec 31;14:718. doi: 10.1186/s12879-014-0718-6. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Time to Virologic Suppression | 12 month | ||
Other | Sustained virologic suppression | 12 month | ||
Primary | Viral Load | 12 month | ||
Secondary | Missed Visit Proportion | Number of missed or "no show" visits divided by number of scheduled appointments | 12 month | |
Secondary | Appointment Adherence | Each participant's proportion of kept appts divided by scheduled appts (mean of the proportions) | 12 month | |
Secondary | Visit Constancy | At least one kept visit in each six-month period | 12 month | |
Secondary | Attended All Scheduled Visits | Attended all scheduled visits | 12 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |